<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1621">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05140057</url>
  </required_header>
  <id_info>
    <org_study_id>0001</org_study_id>
    <nct_id>NCT05140057</nct_id>
  </id_info>
  <brief_title>Preparation Regimens to Improve Capsule Endoscopy Visualization and Diagnostic Yield</brief_title>
  <acronym>PrepRICE</acronym>
  <official_title>Preparation Regimens to Improve Capsule Endoscopy Visualization and Diagnostic Yield: a Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Small bowel capsule endoscopy (SBCE) has become an important tool in clinical practice since&#xD;
      its introduction in 2000. This non-invasive method allows the visualization of small bowel&#xD;
      mucosa, being essential in the management of many conditions, such as suspected small bowel&#xD;
      bleeding, inflammatory bowel diseases and intestinal polyposis syndromes. Despite&#xD;
      recommendations concerning SBCE in different pathologies, there are still some technical&#xD;
      concerns to be addressed. The optimal preparation for SBCE has been one of these&#xD;
      controversial issues.&#xD;
&#xD;
      Currently, the European Society of Gastrointestinal Endoscopy (ESGE) recommends that patients&#xD;
      ingest a purgative agent (2L of polyethylene glycol, PEG) and antifoaming agents for SBCE,&#xD;
      because it was associated with a better visualization. However, it remains unclear which is&#xD;
      the optimal timing for purgative use. Furthermore, the use of a booster agent after capsule&#xD;
      ingestion is already performed in colon capsule endoscopy, but less is known about its&#xD;
      application in SBCE. Also, it remains to be clarified whether a better visualization results&#xD;
      in higher diagnostic yield and impacts patients' outcomes.&#xD;
&#xD;
      Therefore, the global aim of this prospective, randomized, multi-centric study is to&#xD;
      determine the optimal timing and preparation for small-bowel capsule endoscopy (regardless of&#xD;
      the equipment used), comparing four groups of different preparation protocols:&#xD;
&#xD;
        -  Protocol 1) 1L of Moviprep® solution the night before the procedure&#xD;
&#xD;
        -  Protocol 2) 1L of Moviprep® solution up to 2h before the procedure&#xD;
&#xD;
        -  Protocol 3) 0.5L of Moviprep® solution up to 2h before the procedure plus 0.5L of&#xD;
           Moviprep® solution after the capsule had reached the duodenum (assessed with real-time&#xD;
           viewer)&#xD;
&#xD;
        -  Protocol 4) 1L of Moviprep® solution after the capsule had reached the duodenum&#xD;
           (assessed using real-time viewer)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>During the procedure</time_frame>
    <description>Proportion of SBCE with positive findings. findings will be classified based on the Saurin classification; the investigators will consider a positive SBCE when lesions classified as P2 or active bleeding are detected (Saurin classification, Table 2), the remaining will be classified as negative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adequate cleansing rate</measure>
    <time_frame>During the procedure</time_frame>
    <description>A cutoff value of quantitative index ≥ 8 points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of SBCE with vascular lesions</measure>
    <time_frame>During the procedure</time_frame>
    <description>Vascular lesions identified in each tertile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of SBCE with active bleeding</measure>
    <time_frame>During the procedure</time_frame>
    <description>Active bleeding in each tertile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic yield per tertile</measure>
    <time_frame>During the procedure</time_frame>
    <description>Positive findings in each tertile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transit times</measure>
    <time_frame>During the procedure</time_frame>
    <description>Time of entry in the stomach, duodenum and cecum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms experienced during SBCE procedure</measure>
    <time_frame>During the procedure</time_frame>
    <description>Nausea, vomit, bloating, abdominal pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall patients' satisfaction with the cleansing regimen</measure>
    <time_frame>During the procedure</time_frame>
    <description>rated on a 5-point scale: 1 - very easy, 2 - easy, 3 - intermediate, 4 - difficult, 5 - very difficult</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Small bowel cleansing</measure>
    <time_frame>During the procedure</time_frame>
    <description>Mean quantitative index of the distal third of small bowel</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Obscure Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>Protocol 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1L of Moviprep® solution the night before the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1L of Moviprep® solution up to 2h before the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5L of Moviprep® solution up to 2h before the procedure plus 0.5L of Moviprep® solution after the capsule had reached the duodenum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1L of Moviprep® solution after the capsule had reached the duodenum</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Moviprep</intervention_name>
    <description>Bowel preparation for small bowel capsule endoscopy - same product for all groups, different administration timings</description>
    <arm_group_label>Protocol 1</arm_group_label>
    <arm_group_label>Protocol 2</arm_group_label>
    <arm_group_label>Protocol 3</arm_group_label>
    <arm_group_label>Protocol 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be 18 years old or older&#xD;
&#xD;
          -  Present OGIB (either occult or overt)&#xD;
&#xD;
          -  Agree with study's procedures and have signed the informed consent for the study and&#xD;
             SBCE, prior to SBCE procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients performing capsule endoscopy in urgent setting for overt obscure GI bleeding&#xD;
&#xD;
          -  Inpatients or bedridden&#xD;
&#xD;
          -  History of surgery of the esophagus, stomach, small bowel, or colon&#xD;
&#xD;
          -  History of abdominal or pelvic radiation therapy&#xD;
&#xD;
          -  Suspected or confirmed stenosis or occlusion&#xD;
&#xD;
          -  Suspected or confirmed bowel perforation&#xD;
&#xD;
          -  Severe comorbidities, as defined by grade 3 &quot;severe decompensation&quot; in the Adult&#xD;
             Comorbidity Evaluation-27 index (ACE-27)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Patients using narcotics or prokinetics in the week before the SBCE&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Gastroenterology, Centro Hospitalar Vila Nova de Gaia/Espinho</name>
      <address>
        <city>Vila Nova De Gaia</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuela Estevinho</last_name>
      <phone>+351 227865100</phone>
      <email>mmestevinho@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Rolando Pinho</last_name>
    </contact_backup>
    <investigator>
      <last_name>Rolando Pinho</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Catarina Gomes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Ponte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adélia Rodrigues</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuela Estevinho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 5, 2021</study_first_submitted>
  <study_first_submitted_qc>November 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.</investigator_affiliation>
    <investigator_full_name>Maria Manuela Estevinho</investigator_full_name>
    <investigator_title>Medical Doctor, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Small bowel capsule endoscopy</keyword>
  <keyword>Obscure gastrointestinal bleeding</keyword>
  <keyword>Bowel preparation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

